Nu Skin Enterprises (NYSE:NUS – Get Free Report) and BioHarvest Sciences (NASDAQ:BHST – Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations and profitability.
Volatility and Risk
Nu Skin Enterprises has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500.
Valuation and Earnings
This table compares Nu Skin Enterprises and BioHarvest Sciences”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nu Skin Enterprises | $1.49 billion | 0.17 | $160.20 million | $1.10 | 4.71 |
| BioHarvest Sciences | $34.51 million | 1.23 | -$11.14 million | ($0.59) | -3.66 |
Nu Skin Enterprises has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Nu Skin Enterprises and BioHarvest Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nu Skin Enterprises | 3.78% | 7.47% | 4.21% |
| BioHarvest Sciences | -32.54% | -76.03% | -25.30% |
Insider & Institutional Ownership
82.8% of Nu Skin Enterprises shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Ratings
This is a summary of recent recommendations for Nu Skin Enterprises and BioHarvest Sciences, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nu Skin Enterprises | 1 | 1 | 0 | 0 | 1.50 |
| BioHarvest Sciences | 1 | 0 | 1 | 0 | 2.00 |
BioHarvest Sciences has a consensus target price of $10.00, suggesting a potential upside of 362.96%. Given BioHarvest Sciences’ stronger consensus rating and higher probable upside, analysts clearly believe BioHarvest Sciences is more favorable than Nu Skin Enterprises.
Summary
Nu Skin Enterprises beats BioHarvest Sciences on 10 of the 14 factors compared between the two stocks.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
About BioHarvest Sciences
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.
